Research reveals latanoprost-eluting contact lenses may one day replace daily eye drops.
Here is a snapshot of what is happening in the industry.
New antibiotics are scarce—here’s why, and what’s being done about it.
When a patient at risk presents, how do you keep them free of problems?
Consider these alternative uses for this common glaucoma treatment.
An expert weighs in on new ideas in the field of cornea and contact lens care.
New formulations of an old drug may mean better treatments for dry eye.
How should one respond when immune deficiency disrupts the corneal healing response?
Experts discuss the complex mechanics of the human allergic reaction.
Human cells could hold a another potential dry eye treatment.
Could the latest approach to steroid therapy conquer noncompliance once and for all?
Treating with antibacterial drugs can be tempting when presented with an acute infection. First make sure the agent matches the organism.
The FDA recently requested more data on this investigational dry eye drug. What’s known—and what’s next?
Certain contact lens materials may inhibit treatment of ocular surface disease.
Not all drugs are created equal. Be aware of these potential differences.
When we already struggle with patient compliance, how are we going to get patients to add even more steps?
Eye drops may one day compete with lenses.
How do you handle a complex bacterial complication from a simple LASIK procedure?
Managing these infections can be challenging. Here's a breakdown of the most important points to remember.
The recent passing of Professor Brien Holden highlights the continuing need for myopia research.
Human growth hormone may accelerate reepithelialization.
Patients wearing multifocals are just as apt to experience problems as those wearing single vision lenses. But the solutions they need are entirely different.
Lactoferrin delivery could help prevent the effects of oxidative stress on the tear fluid.